Enhabit Inc

Enhabit, Inc. functions as an investment holding company. It provides home health and hospice services. Its Home Health services give patients access to the care they deserve in the comfort of their own homes. From disease and injury management to recovery from surgery, clinicians help patients confidently achieve their healthcare goals. The firm's Hospice services place importance on the comfort of every patient living with a terminal illness. The company was founded in 2014 and is headquartered in Dallas, TX.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Enhabit Inc reports solid Q4 performance amidst strategic changes

Enhabit Inc showcased solid financial performance in Q4 2022, with notable strengths in strategic changes and operational effectiveness.
Challenges include revenue impact from payer shifts and cost pressures, while opportunities lie in revenue growth and optimizing operational efficiency.
The company's focus on acquisitions, patient care optimization, and disciplined growth strategies will be key for future success.
Enhabit's performance, strengths, challenges, and opportunities position it for continued growth and operational excellence in the Home Health and Hospice sectors.

Enhabit Inc reports mixed Q1 results, focuses on growth opportunities

Enhabit Inc saw mixed performance with revenue decline but strong EBITDA guidance.
Challenges include lower patient days in hospice and rising G&A costs.
Opportunities lie in expanding patient accessibility and driving incremental volume.
Overall, Enhabit is focused on independent operation amidst industry consolidation.

Enhabit Inc reports strong growth amidst Medicare Advantage challenges

Enhabit Inc showcased strong performance in non-episodic admissions and cash flow generation, while facing challenges from Medicare Advantage shifts.
The company's strengths lie in recruitment efforts, successful negotiations, and strategic focus on hospice management.
Challenges include maintaining relationships amidst market shifts and diversifying patient mix in hospice.
Opportunities exist in addressing challenges through recruitment strategies, strategic alternatives, and adapting to market changes.

Enhabit reports Q3 revenue decline but secures covenant relief

Enhabit Inc's Q3 2023 performance reflected revenue and EBITDA declines, but strategic initiatives and financial management strength support future growth prospects.
The company's recognition for workplace culture and operational focus are key strengths, while challenges in admissions and financial metrics require targeted solutions.
Opportunities in Medicare pricing, volume growth, and hospice segment trends offer avenues for Enhabit to drive revenue and operational improvements in the coming quarters.

Enhabit Inc reports Q4 results, eyes growth through strategic initiatives

Enhabit Inc's Q4 2023 performance showed mixed results with revenue decline but growth in key segments, setting the stage for strategic initiatives in 2024.
The company's focus on payer innovation contracts, Medicare Advantage transitions, and hospice case management highlights a path for future growth and operational excellence.
While facing challenges in contract predictability and regulatory uncertainties, Enhabit's strengths in contract quality and operational performance present opportunities for sustained success.
Enhabit's financial outlook for 2024 includes a focus on revenue growth, cost management, and strategic expansion, positioning the company for continued progress and profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2023. “In the midst of industry disruption associated with Medicare reimbursement uncertainty, labor pressures and the shift to Medicare Advantage, we continue to deliver on our mission of providing exceptional care to our patients,” said Enhabit's President and Chief Executive Officer, Barb Jacobsmeyer. “We are.

Enhabit Reports Third Quarter 2023 Financial Results

Enhabit (EHAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Enhabit (EHAB) to Report a Decline in Earnings: What to Look Out for

LOS ANGELES, CA / ACCESSWIRE / October 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enhabit, Inc. ("Enhabit" or "the Company") (NYSE:EHAB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Enhabit, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enhabit, Inc. ("Enhabit" or "the Company") (NYSE:EHAB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Enhabit, Inc. and Encourages Investors with Losses to Contact the Firm

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today provided updates on the timing for release of its results for the third quarter ended Sept. 30, 2023, and certain other matters. The Company is in the process of closing its books for the third quarter ended Sept. 30, 2023, and will report its results on Nov. 7, 2023, and host a webcast and conference call on Nov. 8, 2023. Individuals who would like to participate in the conference ca.

Enhabit Home Health & Hospice Announces Date of 2023 Third Quarter Earnings Call; Comments on Limited Waiver and Liquidity

Enhabit posted a $74.1 million loss in the second quarter. The company's board is looking into a possible sale or merger.

Why Shares of Enhabit Slumped on Tuesday

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today announced that it has satisfied the conditions in its Tax Matters Agreement (“TMA”), dated June 30, 2022, with Encompass Health Corporation to conduct a review of strategic alternatives and has formally initiated such process. As part of this process, the board of directors will consider a wide range of options for the Company including, among other things, a potential sale, merger or oth.

Enhabit Home Health & Hospice Confirms Exploration of Strategic Alternatives to Enhance Stockholder Value

Enhabit, Inc. (NYSE:EHAB ) Q2 2023 Earnings Conference Call August 10, 2023 9:00 AM ET Company Participants Jordan Loyd - Mergers & Acquisitions Director, Corporate Development Barb Jacobsmeyer - President and Chief Executive Officer Crissy Carlisle - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies A.J. Rice - Credit Suisse Whit Mayo - Leerink Partners Jason Cassorla - Citigroup Joanna Gajuk - Bank of America Jamie Perse - Goldman Sachs Andrew Mok - UBS Financial Operator Good morning, everyone, and welcome to the Enhabit Home Health & Hospice's Second Quarter 2023 Earnings Conference Call.

Enhabit, Inc. (EHAB) Q2 2023 Earnings Call Transcript

Enhabit (EHAB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.47 per share a year ago.

Enhabit (EHAB) Lags Q2 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2023. “During the second quarter, we negotiated ten new contracts with Medicare Advantage payors, increased our clinical staff with 203 net new full-time nursing hires, and continued to outperform the industry average with a 30-day hospital readmission rate that is 370 basis points better than the national average,”.

Enhabit Reports Second Quarter 2023 Financial Results

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2023, on Aug. 9, 2023, and host a webcast and conference call on Aug. 10, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Aug. 10, 2023 10:00 a.m. Eastern Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 524.

Enhabit Home Health & Hospice Announces Date of 2023 Second Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Jefferies Healthcare Conference. Enhabit's President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Wednesday, June 7, 2023, at 1:30 p.m. ET. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Home Health &.

Enhabit Announces Participation in Upcoming Jefferies Healthcare Conference

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2023. “The first quarter was underscored by progress in two of our critical success factors for 2023. Our sequential admissions growth for home health and hospice was possible due to our continued efforts in recruitment and retention of clinical staff and our payor innovation team negotiating a new national payor agr.

Enhabit Reports First Quarter 2023 Financial Results and Reaffirms Full-Year Guidance

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2023, on May 9, 2023, and host a webcast and conference call on May 10, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 10, 2023 10:00 a.m.

Enhabit Home Health & Hospice Announces Date of 2023 First Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced it has been awarded the Age-Friendly Care at Home Certification from Community Health Accreditation Partner (CHAP). Enhabit is the first home health provider to receive the CHAP certification for its home health agencies in Petersburg, Virginia, and Clermont, Florida. The CHAP certification program brings Age-Friendly Health Systems, an initiative of The John A.

Enhabit Home Health & Hospice Awarded First Age-Friendly Care at Home Certification from CHAP

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC (“Cruiser”) and Harbour Point Capital Management LP (“Harbour Point” ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately.

Enhabit Announces Agreement with Cruiser Capital and Harbour Point Capital

Enhabit, Inc. (NYSE:EHAB ) Q4 2022 Earnings Conference Call February 15, 2023 10:00 AM ET Company Participants Mark Brewer - Chief Investor Relations Officer Barb Jacobsmeyer - President and Chief Executive Officer Crissy Carlisle - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Tao Qiu Key - Stifel A.J. Rice - Credit Suisse Jason Cassorla - Citi Andrew Mok - UBS Joanna Gajuk - Bank of America Larry Solow - CJS Securities Operator Good morning, everyone and welcome to Enhabit Home Health & Hospice's Fourth Quarter 2022 Earnings Conference Call.

Enhabit, Inc. (EHAB) Q4 2022 Earnings Call Transcript

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2022. “Significant changes were required in 2022 to lead important strategies for our future success,” said Enhabit's President and Chief Executive Officer, Barb Jacobsmeyer.

Enhabit Reports Fourth Quarter Results and Issues Full-Year 2023 Guidance

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2022, on Feb. 14, 2023, and host a webcast and conference call on Feb. 15, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit Home Health & Hospice Announces Date of 2022 Fourth Quarter Earnings Call

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the 23rd Annual “New Ideas for the New Year” Investor Conference.

Enhabit Announces Participation in Upcoming 23rd Annual “New Ideas for the New Year” Investor Conference

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced the appointment of Dylan Black as general counsel, effective January 2023.

Enhabit Home Health & Hospice Appoints Dylan Black as General Counsel

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced the acquisition of Southwest Florida Home Care, Inc.'s home health agency located in Fort Myers, Fla.

Enhabit Home Health & Hospice Acquires Southwest Florida Home Care, Inc.'s Fort Myers, Fla. Location

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced the acquisition of Southwest Florida Home Care, Inc.'s home health agency located in Fort Meyers, Fla.

Enhabit Home Health & Hospice Acquires Southwest Florida Home Care, Inc.'s Fort Meyers, Fla. Location

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the BofA Securities Home Care Conference 2022 on Dec. 5, 2022.

Enhabit Announces Participation in Upcoming BofA Securities Home Care Conference 2022

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, announced today its recent placements in Fortune's “30 Best Large Workplaces in Healthcare” awards as well as Modern Healthcare's “Best Places to Work in Healthcare” awards series, highlighting Enhabit's commitment to its people.

News for Enhabit Inc Stock (EHAB)